 Connection
Catherine Derington to Blood Pressure
This is a "connection" page, showing publications Catherine Derington has written about Blood Pressure.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.600 |
|
|
|
-
Derington CG, Berchie RO, Greene T, Jacobs JA, Moran AE, Xu Y, Narita K, Zheutlin AR, Cohen JB, Shimbo D, Bress AP. Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT. J Am Coll Cardiol. 2025 Oct 28; 86(17):1437-1448.
Score: 0.569
-
Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020 04; 75(4):973-981.
Score: 0.385
-
An J, Zhou H, Ni L, Juan R, Portugal C, Romero DI, Reynolds K, Brettler JW, Ong-Su AL, Derington CG, Xu Y, Bress AP, Cohen JB. Trends in Initial Combination Antihypertensive Therapy in a US Health System. Am J Hypertens. 2026 Jun 01; 39(6):787-796.
Score: 0.148
-
Sanuade OA, Addo DK, Smith JD, Carroll AJ, Shimbo D, Talegawkar S, Tucker KL, Jacobs JA, Derington CG, Bress AP. The association of urinary sodium with incident apparent treatment resistant hypertension among African Americans: findings from the Jackson Heart Study. J Hum Hypertens. 2026 May; 40(5):405-412.
Score: 0.147
-
Xu Y, Derington CG, Addo DK, He T, Jacobs JA, Mohanty AF, An J, Cushman WC, Ho PM, Bellows BK, Cohen JB, Bress AP. Trends in Initial Antihypertensive Medication Prescribing Among >2.8?Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. J Am Heart Assoc. 2024 10 15; 13(20):e036557.
Score: 0.132
-
King JB, Sakhuja S, Derington CG, Kolm P, Herrick JS, Berchie RO, Shen J, Greene T, Tajeu GS, Howard G, Levitan EB, Muntner P, Safford MM, Ying J, Weintraub WS, Moran AE, Bress AP, Bellows BK. Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States. J Am Heart Assoc. 2024 09 17; 13(18):e034515.
Score: 0.132
-
Derington CG, Bress AP, Berchie RO, Herrick JS, Shen J, Ying J, Greene T, Tajeu GS, Sakhuja S, Ruiz-Negrón N, Zhang Y, Howard G, Levitan EB, Muntner P, Safford MM, Whelton PK, Weintraub WS, Moran AE, Bellows BK. Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults. Am J Hypertens. 2023 08 05; 36(9):498-508.
Score: 0.122
-
Derington CG, Bress AP, Herrick JS, Jacobs JA, Zheutlin AR, Berchie RO, Conroy MB, Cushman WC, King JB. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020. J Am Heart Assoc. 2023 06 06; 12(11):e028573.
Score: 0.120
-
Derington CG, Bress AP, Moran AE, Weintraub WS, Herrick JS, Cushman WC, Kronish IM, Stults B, Shimbo D, Muntner P, Greene T, Bates JT, Chang TI, Katz LA, Rehman SU, Roumie CL, Tamariz L, King JB. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. Hypertension. 2023 03; 80(3):590-597.
Score: 0.117
-
Bress AP, Greene T, Derington CG, Shen J, Xu Y, Zhang Y, Ying J, Bellows BK, Cushman WC, Whelton PK, Pajewski NM, Reboussin D, Beddu S, Hess R, Herrick JS, Zhang Z, Kolm P, Yeh RW, Basu S, Weintraub WS, Moran AE. Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events. J Am Coll Cardiol. 2021 04 27; 77(16):1977-1990.
Score: 0.104
-
Derington CG, King JB, Delate T, Botts SR, Kroehl M, Kao DP, Trinkley KE. Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PLoS One. 2020; 15(12):e0243371.
Score: 0.101
-
Derington CG, Cohen JB, Bress AP. Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations. J Hum Hypertens. 2020 09; 34(9):617-623.
Score: 0.097
-
Derington CG, King JB, Bryant KB, McGee BT, Moran AE, Weintraub WS, Bellows BK, Bress AP. Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care. Curr Hypertens Rep. 2019 11 07; 21(12):91.
Score: 0.094
-
Zheutlin AR, Chaitoff A, Addo D, Jacobs JA, Derington CG, Stulberg EL, Glynn PA, Modenesi B, Cohen JB, Bress AP. Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment. J Am Heart Assoc. 2026 Apr 21; 15(8):e047792.
Score: 0.037
-
Jacobs JA, Derington CG, Zheutlin AR, King JB, Cohen JB, Bucheit J, Kronish IM, Addo DK, Morisky DE, Greene TH, Bress AP. Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial). J Am Heart Assoc. 2024 02 06; 13(3):e031574.
Score: 0.031
-
Zhang F, Bryant KB, Moran AE, Zhang Y, Cohen JB, Bress AP, Sheppard JP, King JB, Derington CG, Weintraub WS, Kronish IM, Shea S, Bellows BK. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study. J Am Heart Assoc. 2024 01 16; 13(2):e032370.
Score: 0.031
-
King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, Cushman WC, Bress AP. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial. Hypertension. 2023 08; 80(8):1749-1758.
Score: 0.030
-
Zheutlin AR, Addo DK, Jacobs JA, Derington CG, Herrick JS, Greene T, Stulberg EL, Berlowitz DR, Williamson JD, Pajewski NM, Supiano MA, Bress AP. Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT. Hypertension. 2023 07; 80(7):1484-1493.
Score: 0.030
-
Ghazi L, Shen J, Ying J, Derington CG, Cohen JB, Marcum ZA, Herrick JS, King JB, Cheung AK, Williamson JD, Pajewski NM, Bryan N, Supiano M, Sonnen J, Weintraub WS, Greene TH, Bress AP. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial. JAMA Netw Open. 2023 05 01; 6(5):e2314443.
Score: 0.030
-
Jaeger BC, Chen L, Foti K, Hardy ST, Bress AP, Kane SP, Huang L, Herrick JS, Derington CG, Poudel B, Christenson A, Colantonio LD, Muntner P. Hypertension Statistics for US Adults: An Open-Source Web Application for Analysis and Visualization of National Health and Nutrition Examination Survey Data. Hypertension. 2023 06; 80(6):1311-1320.
Score: 0.030
-
Mobley CM, Bryan AS, Moran AE, Derington CG, Zhang Y, Bellows BK. Fixed-Dose Combination Medication Use Among US Adults With Hypertension: A Missed Opportunity. J Am Heart Assoc. 2023 02 21; 12(4):e027486.
Score: 0.029
-
Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 2022 07 01; 5(7):e2220680.
Score: 0.028
-
Zheutlin AR, Mondesir FL, Derington CG, King JB, Zhang C, Cohen JB, Berlowitz DR, Anstey DE, Cushman WC, Greene TH, Ogedegbe O, Bress AP. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 01 04; 5(1):e2143001.
Score: 0.027
-
Zheutlin AR, Derington CG, King JB, Berchie RO, Herrick JS, Dixon DL, Cohen JB, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J. 2022 06; 248:150-159.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|